🗂️ Portfolio 1
44 analysts rated MU in the last 30 days, with 13 Strong Buy, 15 Buy, 5 Hold, 10 Sell and 1 Strong Sell, making this one of the most divided windows across the portfolio. The most recent article, by Scott Gossett on 2026-04-22 at Buy in 'Micron: A Study Of Event Returns, Regime Tailwinds, And DRAM ASP', argues post-earnings weakness fits historical patterns rather than a fundamental shift, and applies an 8x forward P/E to derive a 12-month fair value of $900 per share, with AI hyperscaler CapEx and resilient DRAM pricing underpinning the thesis. The large bearish bloc is anchored by Tech Stock Pros at Sell on 2026-04-20 in 'Micron: Dead Cats Don't Bounce Twice', making MU the highest-dispersion name in the current window with 28 bullish versus 11 bearish analysts.
10 analysts rated COHR in the last 30 days, with 3 Strong Buy, 6 Buy, 1 Hold and 0 Sell. Himalayas Research rated Buy on 2026-04-22 in 'Coherent: A Buy Driven By Robust AI Datacenter Optics Demand', projecting revenue to compound from $5.8 billion in FY2025 to $10.6 billion by FY2028 with EPS growing at a 45% CAGR, supported by a 6-inch InP wafer transition and a new Apple supply deal. On 2026-04-21, KM Capital also rated Buy in 'Coherent: A Cautious Buy Despite Hefty Valuation', noting shares are up 88% year-to-date and that Nvidia's $2 billion investment partnership and 34% year-over-year Datacenter segment growth justify the elevated multiple. The lone Hold in the window reflects valuation caution, but the nine-of-ten Buy or Strong Buy consensus reflects strong conviction in COHR's AI optics positioning.
10 analysts rated MRVL in the last 30 days, with 1 Strong Buy, 7 Buy, and 2 Hold. Cash Flow Venue on 2026-04-22 at Hold in 'Marvell: The Ride Won't Last Forever Given The Valuation (Rating Downgrade)' trimmed their position by 50% and downgraded to Hold, citing the stock's expansion to 40x forward P/E from the low-20x multiple at their initial coverage, and arguing the business's growth prospects do not justify that premium after a 140% share price increase in eight months. Summit Research on 2026-04-22 at Buy in 'Marvell Is Becoming An Indispensable Non-GPU AI Compounder' targets $195 per share in the upside scenario on FY2027 revenue of $12.5B, a 53% increase, contending that a potential XPU attachment opportunity with Google's TPU and MPU programs would cement MRVL's mission-critical role in custom ASIC demand and that the market still underappreciates the multi-year earnings upside from an expanding custom silicon, high-speed networking, and optical connectivity TAM. Net read across the new bodies: Cash Flow Venue downgraded to Hold on the 40x forward P/E after a 140% run, while Summit Research rates Buy targeting $195 on the case that MRVL's custom silicon and networking TAM expansion remain materially undervalued by the market.
15 analysts rated AMD in the last 30 days, with 5 Strong Buy, 4 Buy, 5 Hold, 1 Sell and 0 Strong Sell. The most recent call is Kumquat Research on 2026-04-21 at Strong Buy in 'AMD Stock: My $300 Target Is Close - Here's What Comes Next', arguing that AMD shares have risen 40% in a month and that CPU shortages combined with AI data center momentum will carry shares higher into the second half of 2026. Stone Fox Capital also holds a Strong Buy via 'AMD: $600 Bullseye', while JR Research moved to Hold on 2026-04-20 in 'AMD: Don't Chase Now, Even If You Missed The Ride (Downgrade)', cautioning against chasing at elevated prices. The 5-Hold and 1-Sell minority reflects meaningful dispersion against the 9 bullish calls.
16 analysts rated NBIS in the last 30 days, with 7 Strong Buy, 4 Buy, 4 Hold, and 1 Strong Sell. Yiannis Zourmpanos on 2026-04-22 at Strong Buy in 'Nebius: The Profit Inflection Point' cites Goldman Sachs' $205 price target, driven by 30-54% higher long-term revenue estimates, and argues that NBIS has crossed its profit inflection point as B200 GPU pricing has risen from approximately $4.40/hr to a mean of $5.09/hr with peaks above $6.00/hr, structurally expanding margins, while Finland's 310 MW AI factory reduces energy costs and strengthens the long-term margin profile and geopolitical positioning. Net read across the new bodies: Yiannis Zourmpanos rates Strong Buy, anchoring the thesis on rising GPU pricing as a structural margin driver and Goldman Sachs' $205 target reflecting materially higher long-term revenue expectations.
21 analysts rated AMZN in the last 30 days, with 6 Strong Buy, 13 Buy, 1 Hold, and 1 Sell. JR Research on 2026-04-22 at Hold in 'Amazon: Beware Of Falling Over The Cliff Again (Downgrade)' cites AMZN trading at 32x forward earnings and argues the market has already priced in the $200B CapEx plan, AWS growth, the Anthropic partnership, and Leo satellite ambitions, leaving the stock exposed to free cash flow margin volatility after bullish momentum has run into overdrive. Vishal Patel on 2026-04-22 at Strong Buy in 'How Amazon Is Preparing For The Future' models an average fair value of $293.35, a 17% upside from current prices, and argues that Amazon's integrated flywheel across AWS at a $142B run rate with 24% growth, a $25B Anthropic investment mandating Trainium silicon and securing $100B in future AWS revenue, and over one million warehouse robots projected to save more than $10B annually positions the company for sustained multi-year margin expansion. Net read across the new bodies: Vishal Patel rates Strong Buy on Amazon's compounding integrated ecosystem with a $293.35 fair value, while JR Research downgraded to Hold arguing the same tailwinds are already reflected in the 32x earnings multiple with FCF margin volatility as the key downside risk.
31 analysts rated NVDA in the last 30 days, with 11 Strong Buy, 10 Buy, 5 Hold, 3 Sell, and 2 Strong Sell. Hunting Alphas on 2026-04-22 at Strong Buy in 'Nvidia: Trading At A Rare Discount Just As Its Next AI Supercycle Kicks Off' highlights that NVDA trades at 24.0x 1-year forward P/E, a 23.3% discount to its semiconductor peers' median of 31.3x, and argues this is a rare buying opportunity given a severe GPU shortage supporting pricing power and demand visibility, Foxconn's March 2026 revenue spike suggesting the Vera Rubin platform ramp is progressing on schedule, and local Chinese chipmakers capturing 41% of China's AI accelerator market as a risk to monitor but not yet a deterrent. Net read across the new bodies: Hunting Alphas rates Strong Buy, making the case that NVDA's 24x forward P/E near S&P 500 index levels is anomalous for a company entering the next AI supercycle supported by GPU shortages and a new platform ramp.
No paragraph has been synthesised yet for this ticker. Analyst consensus across 18 analysts: 5 Strong Buy · 5 Buy · 5 Hold · 2 Sell · 1 Strong Sell.
7 analysts rated LUNR in the last 90 days, with 0 Strong Buy, 5 Buy, 2 Hold and 0 Sell. The most recent article, by Byte Sized Alpha on 2026-04-21 at Buy in 'Intuitive Machines: From Lunar Lander To Space Infrastructure Play', sets a 12-month price target of $34.94, arguing the company is transitioning to recurring revenue via the $4.82 billion NASA NSNS contract and the $800 million Lanteris acquisition that expands LUNR into national security. Management guides to nearly 5x revenue growth in 2026, a $943 million backlog, and expected positive adjusted EBITDA, marking an inflection toward profitability. The two Hold-rated analysts in the window acknowledge the contract wins but are more cautious on execution and valuation at current levels.
No paragraph has been synthesised yet for this ticker. Analyst consensus across 12 analysts: 3 Strong Buy · 7 Buy · 2 Hold.
25 analysts rated Celestica in the last 30 days, with 7 Strong Buy, 14 Buy and 4 Hold. No article bodies landed this run, but the breakdown is strongly constructive: 21 of 25 ratings sit in the buy bucket with no Sells at all, keeping conviction Very Strong.
32 analysts rated MSFT in the last 30 days, with 10 Strong Buy, 13 Buy, 7 Hold and 2 Sell. The most recent article, by Konstantinos Kosmidis on 2026-04-21 at Buy in 'Microsoft's Bear Case Is Hard To Buy', argues MSFT trades at 25.1x forward earnings well below its 10-year median, with fears over AI CapEx ROI and agentic disruption overstated, setting up a potential major rerating; Q2 2026 showed strong revenue and income growth though free cash flow declined and CapEx surged to $37.5 billion. The minority bear case is represented by Dmytro Lebid at Sell on 2026-04-17 in 'Microsoft: Don't Buy The Dip; A 30% Correction Is Still Ahead', providing a direct counter to the dominant 23-analyst bullish camp.
33 analysts rated Tesla in the last 30 days, with 2 Strong Buy, 7 Buy, 6 Hold, 7 Sell and 11 Strong Sell, a clearly bearish breakdown. The only captured article, a 2026-04-21 Sell, argues the upcoming SpaceX IPO will divert Musk-focused capital, highlights a ~50,000-unit production-delivery gap, flags automotive gross margin stability above 18% as critical, and calls the near-240x P/E extreme versus peers. The latest rating is a Strong Sell at Very Strong conviction, so bearish sentiment dominates with only 9 buys offsetting 18 sells.
No paragraph has been synthesised yet for this ticker. Analyst consensus across 21 analysts: 7 Strong Buy · 10 Buy · 3 Hold · 1 Sell.
No paragraph has been synthesised yet for this ticker. Analyst consensus across 11 analysts: 1 Strong Buy · 7 Buy · 1 Hold · 1 Sell · 1 Strong Sell.
19 analysts rated Palantir in the last 30 days, with 8 Strong Buy, 7 Buy, 2 Hold and 2 Sell. No article bodies were captured in this run. The 15-to-2 buy-to-sell skew and a Strong Buy latest rating keep conviction Very Strong, though the presence of 2 Sells alongside 8 Strong Buys signals real dispersion around valuation.
12 analysts rated Snowflake in the last 30 days, with 1 Strong Buy, 7 Buy, 3 Hold and 1 Sell. No article bodies were captured in this run. The 8-to-1 buy-to-sell skew and a Very Strong conviction latest rating point to a constructive tilt, with the 3 Holds representing measured caution rather than outright dissent.
No paragraph has been synthesised yet for this ticker. Analyst consensus across 6 analysts: 1 Strong Buy · 3 Buy · 2 Hold.
No paragraph has been synthesised yet for this ticker. Analyst consensus across 7 analysts: 1 Buy · 3 Hold · 3 Sell.
No paragraph has been synthesised yet for this ticker. Analyst consensus across 8 analysts: 1 Strong Buy · 6 Buy · 1 Hold.
🗂️ Portfolio 2
18 analysts rated GOOG in the last 30 days, with 3 Strong Buy, 12 Buy, 2 Hold, and 1 Sell. Michael Del Monte on 2026-04-22 at Strong Buy in 'Alphabet Advances In AI, Positioned To Gain Leadership (Earnings Preview)' reiterates a $480 price target based on 19x estimated FY2028 EV/EBITDA, and argues that Alphabet's deepening custom silicon partnerships with Broadcom and Intel position it to rival Nvidia in neoclouds and enterprise data centers, while the completed Wiz acquisition enhances AI security capabilities and the releases of Gemma 4 and Gemini Robotics-ER 1.6 extend the AI reasoning and physical AI roadmap ahead of Q1 2026 earnings on April 29. Net read across the new bodies: Michael Del Monte rates Strong Buy with a $480 target, grounding the thesis in Alphabet's custom silicon strategy and Google Cloud growth as the near-term Q1 earnings catalyst approaches.
11 analysts rated ANET in the last 30 days, with 4 Strong Buy, 6 Buy, and 1 Hold. Gary Alexander on 2026-04-22 at Buy in 'Arista: Heavy CapEx Demand Keeps Justifying This Stock's Premium' notes that ANET trades at 49x forward P/E, roughly twice as rich as direct competitor Cisco, and maintains Buy because sustained AI-driven data center CapEx demand justifies that premium and Q1 earnings on May 5 are expected as a positive catalyst, with the FY26 outlook likely conservative given ongoing hyperscaler infrastructure spend. Net read across the new bodies: Gary Alexander rates Buy, viewing Arista's 49x forward P/E as defensible given persistent data center CapEx demand and Q1 earnings as the near-term catalyst.
1 analyst rated AEIS in the last 90 days, a Buy. The sole covering thesis, dated 2026-01-27, flagged a 113% surge in data center revenue and strong margin expansion in Q3, arguing continued topline growth into FY26 despite temporary softness in semiconductor and industrial end markets. Valuation trades at a slight premium to the historical average but the analyst still viewed the stock as a solid buy given the growth outlook.
10 analysts rated VRT in the last 30 days, with 1 Strong Buy, 7 Buy, and 2 Hold. Steven Fiorillo on 2026-04-22 at Buy in 'Vertiv Holdings: The Market Just Handed Long-Term Investors A Gift' points to full-year 2026 revenue guidance raised to $13.5-$14.0 billion with adjusted EPS raised by $0.33 at the midpoint and FCF guidance of $2.1-$2.3 billion, and argues that the post-Q1 selloff on overseas weakness is a buying opportunity given 30% year-over-year Q1 revenue growth, Americas segment organic sales surging 44% year-over-year for three consecutive quarters and now representing 62% of total revenue, and Vertiv's technical partnerships and product integration with Nvidia positioning the company for multi-year AI infrastructure growth. Net read across the new bodies: Steven Fiorillo rates Buy, viewing the market's negative reaction to overseas weakness as a mispricing against Vertiv's $13.5-$14.0 billion FY2026 revenue guidance and sustained Americas segment momentum.
3 analysts rated ISRG in the last 90 days, with 2 Buy and 1 Hold. Dhierin Bechai on 2026-04-22 at Buy in 'Intuitive Surgical: Strong Quarter, Mispriced Stock' sets a $584.50 price target and argues that Q1's 23% revenue growth, $0.39 EPS beat, and raised 2026 procedure growth guidance to 13.5%-15.5% validate ISRG's market-leading robotic surgery platform, with softness in China and Japan and healthcare CapEx sensitivity viewed as transient pressures that do not undermine the recurring revenue model. StockBros Research on 2026-04-22 at Hold in 'Intuitive Surgical Q1 Earnings Review: Don't Overpay For Quality' acknowledges the strong Q1 results but rates Hold because the 47x TTM P/E is too high relative to expected low-to-mid-teens EPS growth, arguing there is insufficient margin of safety at current levels. Net read across the new bodies: Dhierin Bechai and StockBros Research split on valuation - Bechai rates Buy at a $584.50 target seeing the stock mispriced despite transient headwinds, while StockBros holds at Hold arguing the 47x TTM P/E offers too little margin of safety against low-to-mid-teens earnings growth.
8 analysts rated Allstate in the last 90 days, with 1 Strong Buy, 4 Buy and 3 Hold. The most recent thesis, dated 2026-04-14 at Hold, credits disciplined underwriting, catastrophe management and an attractive sub-6x PE but flags limited premium growth, especially in auto. Bullish views include a 2026-02-27 Buy framing fair value at $240+ on 8.5x forward earnings after an 8% dividend hike and a $4B buyback, and a 2026-01-29 Strong Buy arguing ALL at roughly 6.4x earnings offers a more attractive risk-reward than Chubb. The Hold camp continues to push back on cyclical auto exposure and weather sensitivity.
14 analysts rated META in the last 30 days, with 3 Strong Buy, 8 Buy, 1 Hold and 2 Sell. Both new articles filed on 2026-04-21 are rated Hold: Rowan Street Capital in 'Meta Platforms: The Long Game' highlights Meta's roughly 1,300% cumulative return since IPO and notes AI video tools generating $10 billion in annual recurring revenue growing three times faster than overall advertising, while holding on near-term valuation; Justin Purohit in 'Meta Q1 Earnings Preview: AI Expansion And Its Ad Business, Shares Fairly Valued' previews the April 29 Q1 release and sees shares as reasonably priced, with Wall Street consensus at Strong Buy and a $855 price target. Despite both fresh articles landing at Hold, the broader 30-day window is strongly bullish at 11 Strong Buy or Buy versus 2 Sell, and management executive options that pay out only if Meta's stock reaches $3,727 per share by 2031 underscore long-term institutional confidence.
17 analysts rated ASML in the last 30 days, with 0 Strong Buy, 10 Buy, 6 Hold and 1 Sell. The most recent article, by Shubhm Mitessh Thakkar on 2026-04-21 at Hold, sets a price target of $1,291 against the then-closing price of $1,459.80, implying roughly 12% downside, citing Q1 beats on revenue and net income but flagging H2 2026 revenue guidance that assumes near-20% growth as optimistic and warning that potential U.S. export restrictions on DUV tools could shrink China's share of ASML revenue from 33% to around 20%. The Buy-heavy majority views ASML as a critical AI infrastructure bottleneck with a defensible EUV monopoly, while the Hold and Sell minority point to stretched valuation and China export risk as near-term overhangs.
6 analysts rated ATI in the last 90 days, with 2 Strong Buy, 2 Buy and 2 Hold. Two articles landed on 2026-04-18: a Strong Buy lifting the price target to $200.83 after the prior $163.13 target was reached, citing surcharge pass-throughs and operating leverage, and a Buy crediting 32% YoY adjusted EPS growth and a 400bps HPMC margin expansion on Boeing and Airbus long-term agreements. A 2026-03-24 Hold at a $139.86 PT argues the aerospace supercycle is already priced in at ~34x forward P/E. Aerospace and defense demand is the common thread; the split is on valuation.
9 analysts rated ARM in the last 90 days, with 4 Buy, 4 Hold and 1 Sell. The most recent article, dated 2026-04-17 at Hold, argues the forward P/E near 90x prices in unrealistic growth given stagnant revenue and a $170B market cap post-51% rally. Bullish theses dated 2026-04-07, 2026-04-06 and 2026-03-25 lean on the AGI CPU opportunity (projected $1B revenue in FY27-28, $15B by 2031), 27% royalty growth and 21 CSS licenses, while a 2026-03-18 Hold was an upgrade citing resilient v9 and CSS royalty momentum. Dispersion is real: buyers are paying up for data center exposure, holders push back on valuation.
5 analysts rated Constellation Energy in the last 90 days, with 2 Buy, 1 Hold, 1 Sell and 1 Strong Sell. The most recent article on 2026-04-16 is Hold, flagging the $29B Calpine acquisition as adding over $2/share to 2026 EPS with $11-$12 guidance, and calling $250/share an attractive entry. Bullish views on 2026-03-25 and 2026-02-20 frame CEG as the nuclear backbone of AI data center demand with Microsoft, Meta, Nvidia and US government contracts, while a 2026-03-16 Sell and 2026-02-23 Strong Sell push back on Calpine-driven debt, lack of 2026 guidance clarity and zero-to-negative earnings growth. Dispersion here is unusually wide.
16 analysts rated Super Micro Computer in the last 30 days, with 2 Strong Buy, 1 Buy, 4 Hold, 7 Sell and 2 Strong Sell, a clearly bearish breakdown. Recent articles reinforce the skew: a 2026-04-10 Sell sets fair value at $16.68 implying 28% downside on weak earnings and customer concentration, a 2026-03-31 Sell flags alleged illegal exports and a 6.4% Q2 gross margin with 63% of revenue from a single customer, and a 2026-03-26 Strong Sell argues SMCI is effectively un-analyzable given governance concerns. The lone counter is a 2026-04-07 high-risk Buy with a $36.04 target contingent on executive departures.
2 analysts rated SiTime in the last 90 days, both Hold. The 2026-04-09 Hold treats the $1.5B Renesas timing-business acquisition as an inflection point with balanced risk-reward pending Q1 2026 results, regulatory progress and refinancing terms. The 2026-03-31 Hold highlights a 60x FY2026 P/E despite the Apple internal-modem MEMS-oscillator win and the Renesas-driven revenue doubling. With all ratings Hold and no buys or sells, the consensus is neutral.
5 analysts rated Teradyne in the last 90 days, with 3 Buy and 2 Hold. The most recent Buy on 2026-04-09 highlights a ~60% YTD rally, progress toward becoming a secondary GPU test supplier likely for Nvidia, and robust 1Q 2026 guidance. A 2026-04-06 Hold argues the 49.44x forward P/E, pulled-forward upside to a $333 long-term price target and overbought technicals make the stock a Hold. A 2026-03-06 Buy and 2026-01-22 Buy both frame TER as a core AI infrastructure test and automation provider.
7 analysts rated SoundHound AI in the last 90 days, with 1 Strong Buy, 1 Buy, 3 Hold and 2 Sell. The window contains unusually sharp dispersion on the same day: on 2026-04-07, a Strong Buy upgrade cites nearly 100% FY2025 revenue growth, 100+ new deals and a $40.1M Q4'25 GAAP profit, while a Hold on the same date flags 11x forward EV/revenue versus a sector median below 3x and stock-based comp at 47.7% of revenue. A 2026-03-19 Sell pushes cash-burn concerns, while a 2026-03-13 Buy and Hold pair split on valuation at EV/Sales 13.10x.
2 analysts rated Trane Technologies in the last 90 days, a Buy and a Hold. The 2026-04-07 Hold notes Q4 2025 revenue up 5.6% YoY with strong Americas bookings but argues a 32.9x P/E well above the 5-year average leaves TT fully priced as COGS rose 7.2%. The earlier 2026-02-04 Buy upgrade leans on a forward-earnings reset to 28x, commercial HVAC orders up ~120% YoY (especially in data centers), a record $7.8B backlog, and a $545 FY28 share-price target implying 28% upside.
1 analyst rated Modine in the last 90 days, a Hold. Two captured articles show a rating change: the most recent on 2026-04-01 is a Hold downgrade flagging an EV/EBITDA of 25.44x and P/E of 43x after the January 2026 rally, with a $165s technical correction target, even as data center revenues rose 78% YoY. An earlier 2026-01-24 Buy at a $239.80 long-term target praised the capacity ramp. Direction-of-travel is a recent downgrade despite intact fundamentals.
5 analysts rated Comfort Systems USA in the last 90 days, with 2 Buy and 3 Hold. The most recent article on 2026-03-31 is Buy on a 41.7% YoY Q4 FY25 revenue surge to $2.65B and a $12B backlog that doubled, but subsequent Holds on 2026-03-26, 2026-02-10 and 2026-01-28 all argue the forward P/E around 35x already prices in the 26% EBITDA growth scenario and a DCF values shares 10-13% below market. A 2026-02-26 Buy treats the premium valuation as earned. The direction-of-travel on ratings is sideways with a slight downgrade bias.
5 analysts rated MongoDB in the last 90 days, with 2 Buy and 3 Hold. Buys dated 2026-03-31 and 2026-03-29 argue the ~40% YTD drop post-earnings is a compelling entry, citing 26.75% YoY Q4 FY26 revenue growth to $695.1M and a debt-free $2B+ cash balance. Holds on 2026-03-12 and two on 2026-02-26 push back on FY27 guidance implying just 17% growth and a premium valuation with limited near-term upside. The latest rating tilt is Hold at Strong conviction.
1 analyst rated nVent Electric in the last 90 days, a Buy. The sole article on 2026-03-25 highlights data center demand at 45% of sales heading toward 50%+ by FY26, a Systems Protection vertical growing 34% with margins above 20% anchored by liquid cooling, and models an 18% revenue growth, 22% margin, 22x EV/EBITDA scenario. Risks cited are tariff headwinds and competition.
4 analysts rated Tower Semiconductor in the last 90 days, with 1 Strong Buy, 1 Buy and 2 Hold. The most recent article on 2026-03-25 is a Hold arguing the forward PEG is 205% above the sector median despite consensus 62% 2027 YoY growth. A 2026-03-20 Buy initiates on silicon photonics leadership with 70%+ of new capacity reserved through 2028. A 2026-03-13 Strong Buy details silicon photonics revenue more than doubling from $106M in 2024 to $228M in 2025 with gross margins potentially expanding from 23% to nearly 40%. A 2026-02-11 Hold reiterates overvaluation after a 200% rally.
1 analyst rated MKS Instruments in the last 90 days, a Buy. The sole article on 2026-03-24 initiates coverage at Buy citing 22.7x FY2026 P/E undervaluation versus peers, an accelerating Electronics and Packaging segment tied to AI-related PCB demand, and manageable debt. With only one rating in the window, conviction reads Moderate.
7 analysts rated Incyte in the last 90 days, with 2 Strong Buy, 4 Buy and 1 Hold. The freshest Buy on 2026-03-22 highlights Jakafi's $3.09B 2025 sales up 11% YoY and Opzelura at $678M up 33% as the company prepares for the 2028 patent cliff. A 2026-03-17 Buy argues the market overemphasizes the cliff given non-Jakafi growth above 50% YoY, a 2026-03-16 Strong Buy anchors on 12.5x 2026 EPS and four near-term regulatory submissions, and a 2026-02-18 Buy points to the ruxolitinib franchise. The lone Hold on 2026-03-17 is a biotech portfolio piece not a direct call against INCY.
1 analyst rated Regal Rexnord in the last 90 days, a Buy. The sole article on 2026-03-21 frames the 'buy' on management's 2027 targets of $6.4-$7B revenue and $1.675B EBITDA, with RRX trading at a discount to peers and potential 15-20% annualized upside even without multiple expansion. Moderate conviction given the single rating.
3 analysts rated Carrier Global in the last 90 days, with 1 Buy and 2 Hold. Articles dated 2026-03-18 (Hold) and 2026-02-06 (Hold) argue CARR trades at a 40% discount to peer PE that is justified by 1.1% revenue growth versus 6.4% for peers, and that Q4 2025 revenue fell 6% YoY missing revised guidance. The lone Buy, also dated 2026-02-06, credits data center demand and aftermarket growth offsetting weak North American residential, with 2026 EPS growth of 8.1% to $2.80.
4 analysts rated Eaton in the last 90 days, with 2 Buy and 2 Hold, an even split. The most recent Buy, dated 2026-03-12, lowers the target to $373 citing 8% revenue CAGR to 2030 and record backlogs with 2026 growth normalization. The 2026-03-10 Hold and 2026-02-03 Hold both push back on premium valuation despite a near-$20B backlog and the pending Mobility spin-off. A 2026-02-04 Buy argues ETN is more of a value after peers have rallied.
1 analyst rated MasTec in the last 90 days, a Hold. The 2026-03-03 article is a downgrade to Hold after record Q4 and full-year 2025 results and 2026 revenue guidance of $17B up 19%, citing premium multiples (forward EV/EBITDA 23.7x, P/E 37x) and overbought technicals. Direction-of-travel is a very recent downgrade rather than a fundamental concern.
1 analyst rated MACOM Technology in the last 90 days, a Hold. The sole article on 2026-02-06 praises MTSI's positioning in RF semis with 24% YoY revenue growth, expanding margins and a 1.3x book-to-bill, but concludes that a forward EPS multiple above 50x leaves risk-reward unattractive. With only one rating, conviction is Moderate.
🗂️ SA top stocks
16 analysts rated TSM in the last 30 days, with 3 Strong Buy, 9 Buy, and 4 Hold. Kennedy Njagi on 2026-04-22 at Buy in 'Taiwan Semiconductor: The AI Boom Is Broadening, And That Matters' notes TSM's forward non-GAAP PEG of 0.75x, a 48.53% discount to the sector median, and argues that AI demand is broadening from hyperscalers to enterprise and edge deployment, with TSM's 32.88% forward revenue growth and 31.44% long-term EPS growth well above sector medians supporting continued outperformance. George Atuan, CFA on 2026-04-21 at Buy in 'TSMC: The Market Is Pricing A Foundry Like A Cyclical. It Is Not One.' estimates DCF-based fair value approximately 30% above current price, citing Q1 revenue growth of 35.1% year-over-year with high-performance computing at 61% of the revenue mix and 3nm nodes above 20% of wafer revenue, and arguing that TSM's monopoly position across every major AI chip including Nvidia Blackwell, AMD MI350, Apple A19, and Broadcom custom silicon makes the 25.8% P/E discount to peers an opportunity rather than a warning. Net read across the new bodies: Kennedy Njagi and George Atuan agree on Buy and converge on the thesis that TSM is priced as a cyclical while operating as an irreplaceable structural franchise, with Atuan quantifying approximately 30% DCF upside and Njagi emphasizing the broadening AI demand base as the growth driver.
13 analysts rated CRDO in the last 30 days, with 6 Strong Buy, 6 Buy, and 1 Hold. Quantryon Capital on 2026-04-21 at Buy in 'Credo's Optical Pivot Is Changing The Entire Narrative' targets $500M+ in optical revenue by FY27 and $1.3B+ in total revenue by FY26, and argues that the DustPhotonics acquisition transforms CRDO from a component supplier into a vertically integrated interconnect platform with full signal-path control, noting that the stock's approximately 24x forward price-to-sales ratio reflects market belief in over 50% revenue growth and durable approximately 50% non-GAAP operating margins, while flagging that execution on optical integration and margin preservation are critical to sustaining the current valuation. Net read across the new bodies: Quantryon Capital rates Buy, viewing CRDO's optical pivot as a genuine platform transformation targeting $1.3B+ in FY26 revenue but remaining cautious on execution risk in the vertical integration.
7 analysts rated CIEN in the last 90 days, with 1 Strong Buy, 5 Buy, and 1 Hold. Kennedy Njagi on 2026-04-21 at Strong Buy in 'Ciena's New Growth Phase Is Inside The Data Center' points to CIEN's forward non-GAAP PEG of 1.34x against a sector median of 1.45x, and argues that Ciena has moved beyond data center egress to become integral to distributed AI cluster architectures, supported by Q1 2026 revenue of $1.43B with 33% year-over-year growth, a 76% surge in direct cloud provider revenue now representing 42% of total revenue, and a $2B backlog increase to $7B with new orders extending into 2027. Net read across the new bodies: Kennedy Njagi rates Strong Buy, anchoring conviction on CIEN's deepening integration into AI cluster architectures backed by a $7 billion backlog and a PEG at a modest discount to the sector median.
23 analysts rated APP in the last 30 days, with 8 Strong Buy, 11 Buy, 2 Hold, 1 Sell and 1 Strong Sell. The book skews heavily positive at 19 of 23 in the Buy-or-better bucket, and the most recent call is Daniel Jones on 2026-04-18 at Buy titled 'AppLovin's Fantastic Upside Necessitates A Downgrade', a trim-from-Strong-Buy move rather than a bearish turn. Earlier April pieces from Hunting Alphas, Danil Sereda, Kennedy Njagi and Khaveen Investments all reiterated Buy or Strong Buy on valuation and sustained Axon growth.
9 analysts rated Barrick in the last 90 days, with 2 Strong Buy, 6 Buy, 1 Hold, 0 Sell and 0 Strong Sell. The most recent call is The Curious Analyst on 2026-04-16 at Strong Buy titled 'Barrick's North America IPO Is The Catalyst I Was Waiting For', reinforcing a spinoff/IPO thesis also backed by Danil Sereda's 2026-04-03 Buy and Louis Gerard's 2026-03-30 Buy on structural gold tailwinds. The only dissent is Hunting Alphas' 2026-04-10 Hold flagging a royalty shocker and margin squeeze on the spinoff.
8 analysts rated GM in the last 90 days, with 2 Strong Buy, 2 Buy, 4 Hold, 0 Sell and 0 Strong Sell. The book tilts cautious with half the calls at Hold, and the most recent bullish entries are The Sharpe Quest on 2026-04-10 at Buy and Mike Zaccardi on 2026-04-09 at Buy 'General Motors: Free Cash Flow Hums Along, Raising My Target Again'. The Hold cluster from Virginia Backaitis, Doron Levin and Daniel Jones keeps pushing back on valuation and EV demand, with Jones' February piece explicitly framed as a downgrade after a great ride.
6 analysts rated HUT in the last 90 days, with 0 Strong Buy, 3 Buy, 3 Hold, 0 Sell and 0 Strong Sell. The book splits evenly between Buy and Hold, and the most recent entries tilt bullish: Emanuel Nemec on 2026-04-04 at Buy citing the River Bend expansion and Petri Dish Reports on 2026-04-02 at Buy despite a $248M loss. The Hold cluster from Daniel James, Jason Ditz and Mandela Amoussou keeps flagging operating-profitability and valuation concerns against the AI-infrastructure narrative.
Only 1 dated analyst call is captured for GMED in the last 90 days, a Buy from Blake Winiecki on 2026-03-19 titled 'Globus Medical: Great Value, Momentum, And Earnings Growth'. Other roster entries for Stephen Ayers, The Value Investor and Bret Jensen appear as undated Hold placeholders rather than fresh ratings, so the window effectively rests on that single data point.